Latest Close
$21.60
News
ACAD
ACADIA Pharmaceuticals Inc. News
This news view pulls recent coverage and headlines tied to ACAD.
1y Change
-$1.35 (-5.88%)
Market Cap
$3.7B
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
BioPharma Dive • Jun 12, 2026
Read articleA Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness
Simply Wall St. • Jun 7, 2026
Read articleAcadia (ACAD) Down 3.7% Since Last Earnings Report: Can It Rebound?
Zacks • Jun 5, 2026
Read articleIs MYGN Stock a Buy at 0.4x Sales? What Investors Should Weigh
Zacks • May 28, 2026
Read articleMYGN Cancer Care Strategy: What's Driving 2026 Growth Plans
Zacks • May 27, 2026
Read articleACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth
MarketBeat • May 19, 2026
Read article